MIRA Pharmaceuticals, Inc. Accounts Payable and Accrued Liabilities, Current
MIRA Pharmaceuticals, Inc. (MIRA) had Accounts Payable and Accrued Liabilities, Current of $723.35 thousand as of 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2025-03-28
- 2024-12-31: Accounts Payable and Accrued Liabilities, Current $723.35K.
- 2024-09-30: Accounts Payable and Accrued Liabilities, Current $692.83K.
- 2024-06-30: Accounts Payable and Accrued Liabilities, Current $782.14K.
- 2023-12-31: Accounts Payable and Accrued Liabilities, Current $538.56K.
| Period end | Accounts Payable and Accrued Liabilities, Current |
|---|---|
| 2024-12-31 | $723.35K 10-K · filed 2025-03-28 |
| 2024-09-30 | $692.83K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $782.14K 10-Q/A · filed 2024-08-16 |
| 2023-12-31 | $538.56K 10-K · filed 2025-03-28 |
| 2023-09-30 | $779.57K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $659.10K 10-Q · filed 2023-09-15 |
| 2022-12-31 | $811.74K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |